# Flanax

NDC: 27854-160
Generic name: Naproxen Sodium
Labeler / Manufacturer: Belmora LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180115

FDA application: ANDA204872

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27854-160"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27854-160
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c099d45-f03a-4161-a6af-8fe5965f2748